Dec
18
Bystolic™, a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
Filed Under (Blood Pressure) by Content Keyword RSS
Dec
18
Bystolic™, a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
Filed Under (Blood Pressure) by Content Keyword RSS
Dec
18
Bystolic™, a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
Filed Under (Blood Pressure) by Content Keyword RSS
New York, NY (PRWEB) December 19, 2007 - www.Frx.com [Forest Laboratories, Inc.] (NYSE: FRX) and Mylan Inc. (NYSE: MYL) announced today that the novel beta blocker Bystolic™ (nebivolol) was...